Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test

The Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV combination test received emergency use authorization approval by the United States Food and Drug Administration in December 2020, and Health Canada approval in January 2021. The performance characteristics of the GeneXpert Xpert Xpress SARS-CoV-2/Flu/RSV...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Grant, Zubrzycki, Arek, Henry, Michele, Ranadheera, Charlene, Corbett, Cindi, Meyers, Adrienne F.A., Sandstrom, Paul A., Becker, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040320/
https://www.ncbi.nlm.nih.gov/pubmed/35262002
http://dx.doi.org/10.1016/j.jcvp.2021.100014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040320/
https://www.ncbi.nlm.nih.gov/pubmed/35262002
http://dx.doi.org/10.1016/j.jcvp.2021.100014

Ejemplares similares